"Our physicians are Board Certified Dermatologists offering many years of experience mixed with the latest knowledge and today’s technology. We strive to provide excellent service in medical dermatology, treatment and research. Surrounded with a first class team of personnel, Drs. Abramovits, and Saxton-Daniels want their patients to feel that we provide the best Dermatology has to offer, in a friendly and compassionate atmosphere."

During the past decade, Dermatology Treatment and Research Center conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 19 clinical trials were completed, i.e. on average, 63.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 12 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatology Treatment and Research Center" #1 sponsor was "Pfizer" with 6 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Stiefel, a GSK Company" with 3 trials sponsored, "AnaptysBio, Inc." with 2 trials sponsored and "Asana BioSciences" with 2 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology Treatment and Research Center" #1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "Dermira, Inc." with 2 trials as a collaborator, "Dow Pharmaceutical Sciences" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Dermatology Treatment and Research Center" are "Atopic Dermatitis" (13 trials), "Psoriasis" (10 trials), "Plaque Psoriasis" (7 trials), "Dermatitis, Atopic" (3 trials) and "Acne Vulgaris" (2 trials). Many other conditions were trialed in "Dermatology Treatment and Research Center" in a lesser frequency.

Most popular intervention types in "Dermatology Treatment and Research Center" are "Drug" (39 trials), "Biological" (6 trials), "Other" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Lebrikizumab" (3 trials), "ASN002" (2 trials), "BMS-986165" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dermatology Treatment and Research Center" are 45 trials for "All" genders.

Currently, there are NaN active trials in "Dermatology Treatment and Research Center". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Dermatology Treatment and Research Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Dermatology Treatment and Research Center, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".